MYNZ
Mainz Biomed BV
NASDAQ: MYNZ · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.41
-3.73% today
Updated 2026-05-01
Market cap
$7.90M
P/E ratio
—
P/S ratio
16.01x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$1 – $5
Volume
0.8M
Mainz Biomed BV (MYNZ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-416495.00 | $-468737.00 | $-3.22M | $-14.77M | $-21.94M | $-17.09M |
| Capital expenditures | $9685.00 | $9685.00 | $16705.00 | $658483.00 | $1.90M | $254949.00 |
| Depreciation | $53042.00 | $60462.00 | $69929.00 | $379798.00 | $866412.00 | $1.02M |
| Stock-based comp | $0.00 | $0.00 | $6.43M | $9.82M | $4.01M | $1.14M |
| Free cash flow | $-426180.00 | $-478422.00 | $-3.24M | $-15.43M | $-23.84M | $-17.34M |
| Investing cash flow | $-9685.00 | $-9685.00 | $1.20M | $-658483.00 | $-1.90M | $-198817.00 |
| Financing cash flow | $423995.00 | $396681.00 | $10.61M | $23.94M | $14.23M | $16.60M |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |